Breast Progression TMA
Provided by CHTN/NCI Specialized Tissue Microarray Resource
This resource has a service and/or shipping fee.
Collaboration for use of specimens is not required.
Contact Repository
Contact: Resource Coordinator
Address: CHTN, Mid-Atlantic Division
University of Virginia
Dept. of Pathology
Box 800904
Charlottesville, VA 22908
URL(s):
http://cdp.nci.nih.gov/tma.html
Email: tissueresources@imsweb.com
Specimen Data
- Organ Site
- Breast
- Histology / Tumor Type
- Ductal Invasive Carcinoma, Ductal in Situ Carcinoma
- Specimen Type
- Tissue Microarray (TMA)
- Other Specimen Types in this Collection (if any)
- Not Available
- Preservation Type
- Formalin-Fixed Paraffin-Embedded
Available Data
- Demographic Information
- Pathology Report
Type of Collection
- Collaboration
- NIH/NCI
Application Eligibility
- Academia
- Government
- Non-Profit
- Commercial
- Non-U.S. Organization
Publications
- Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation. Morrow KA, Das S, Metge BJ, Ye K, Mulekar MS, Tucker JA, Samant RS, Shevde LA. The Journal of biological chemistry. 2011 Nov 18;286(46):40376-85
- Grading breast cancer on microarray samples: comparison with Nottingham grade, and use of boosting classification. Dalton L, Page DL. Histopathology. 2012 Sep;61(3):497-508
- Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Serrero G, Hawkins DM, Yue B, Ioffe O, Bejarano P, Phillips JT, Head JF, Elliott RL, Tkaczuk KR, Godwin AK, Weaver J, Kim WE. Breast cancer research : BCR. 2012 Feb 08;14(1):R26
- Elevated TRF2 in advanced breast cancers with short telomeres. Diehl MC, Idowu MO, Kimmelshue KN, York TP, Jackson-Cook CK, Turner KC, Holt SE, Elmore LW. Breast cancer research and treatment. 2011 Jun;127(3):623-30